Overviewing Phase 2 Data of Imlifidase in Guillain-Barré Syndrome: Elisabeth Sonesson, PhD
Abstracts for the 2025 CMSC Annual Meeting Are Now Live!
Early Data Support Continued Development of NVG-2089 as IVIg Alternative in CIDP
Holistic Strategies and to Promote Remyelination in MS